Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
09/29/2010 | EP2231700A1 Vaccine comprising a ribosomal protein extract (rpe) and optionally a th1-promoting adjuvant |
09/29/2010 | EP2231699A2 Vaccines for brucellosis |
09/29/2010 | EP2231696A2 Methods and compositions for detection of ehrlichia chaffeensis (vlpt) |
09/29/2010 | EP2231694A1 Cationic core-shell peptide nanoparticles |
09/29/2010 | EP2231181A1 New vaccine for the treatment of mycobacterium related disorders |
09/29/2010 | EP2231177A1 Trophic factor for the treatment of retinal degenerative diseases |
09/29/2010 | EP2083856B1 Peptides for desensibilization against allergens |
09/29/2010 | EP1907532B1 Biological materials and uses thereof |
09/29/2010 | EP1881850B1 Glp-1 pegylated compounds |
09/29/2010 | EP1729803B1 Therapeutic use of anti-cs1 antibodies |
09/29/2010 | EP1692159B1 Tgf-beta1 binding and supported peptides |
09/29/2010 | EP1651674B1 Ups as modifiers of the beta catenin pathway and methods of use |
09/29/2010 | EP1572952B1 Novel polynucleotide and polypeptide sequences and uses thereof |
09/29/2010 | EP1028972B1 Multi-mer peptides derived from hepatitis c virus envelope proteins for diagnostic use and vaccination purposes |
09/29/2010 | CN1948339B Preparation and purification of telomerase activity inhibition protein |
09/29/2010 | CN1935254B Method for neuregulin treating cardio vascular disease, and composition |
09/29/2010 | CN101849011A Regulatory elements associated with CBF transcription factor of rye |
09/29/2010 | CN101849009A Plants having increased yield-related traits and a method for making the same |
09/29/2010 | CN101848995A Recombinant north american type 1 porcine reproductive and respiratory syndrome virus and methods of use |
09/29/2010 | CN101848938A Modified plant defensin |
09/29/2010 | CN101848934A Neuroprotection using NAP-like and SAL-like peptide mimetics |
09/29/2010 | CN101848933A Complexes of TRPC domains and SESTD1 domains and methods and uses involving the same |
09/29/2010 | CN101848932A Peptide having hypotensive activity |
09/29/2010 | CN101848931A Plants with altered root architecture, related constructs and methods involving genes encoding exostosin family polypeptides and homologs thereof |
09/29/2010 | CN101848930A Plasmid-encoded neurotoxin genes in clostridium botulinum serotype a subtypes |
09/29/2010 | CN101848929A Streptococcus pneumoniae pilus antigens |
09/29/2010 | CN101848928A Staphylokinase variant |
09/29/2010 | CN101848926A Peptide capable of binding to immunoglobulin |
09/29/2010 | CN101848735A Novel neurturin conjugates for pharmaceutical use |
09/29/2010 | CN101848730A Capsid proteins and uses therefore |
09/29/2010 | CN101848729A Adenoviral vector encoding malaria antigen |
09/29/2010 | CN101848720A 糖尿病治疗剂 Therapeutic agents for diabetes |
09/29/2010 | CN101845458A Expression vector of human transferrin, construction method thereof and application thereof |
09/29/2010 | CN101845454A Method for expressing pseudoplectania nigrella mature peptide in recombinant pichia pastoris |
09/29/2010 | CN101845443A Tomato glutaredoxin gene SlRX1 as well as cloning method and application thereof |
09/29/2010 | CN101845442A Method for preparing human interleukin 28A by silkworm bioreactor and pharmaceutical application thereof |
09/29/2010 | CN101845439A Method for using silkworm cultured cell to express antibacterial peptide Cecropin B |
09/29/2010 | CN101845438A Sensitive diagnosis and relative treatment for cancers through 20 tumor specific related genes and products |
09/29/2010 | CN101845096A Cu2<+> specific monoclonal antibody and preparation method thereof |
09/29/2010 | CN101845094A Double-cross-linking chemical synthesis method of citrinin-protein-coupled antigen and preparation method of anti-citrinin monoclonal antibody |
09/29/2010 | CN101845093A Purification method for large-scale production of nerve growth factors in cobra venin |
09/29/2010 | CN101845092A Antimicrobial peptide Ea-CATH1 of Equus asinus and genes and application thereof |
09/29/2010 | CN101845091A Metastin derivatives and use thereof |
09/29/2010 | CN101845090A Rat RANK extracellular protein crystal |
09/29/2010 | CN101845089A Method for large-scale production of neurotoxin in cobra venin and reduction of neurotoxicity |
09/29/2010 | CN101845088A Ammonium salt absorption-related protein and encoding gene and application thereof |
09/29/2010 | CN101845087A Protein TaPaO associated with plant senescence induction and male sterility, coding gene and application thereof |
09/29/2010 | CN101845086A Rice leaf-shaped regulatory gene NRL1 and application thereof |
09/29/2010 | CN101845085A Wild soybean AP1 type protein and coding gene and application thereof |
09/29/2010 | CN101845084A Recombination polypeptide serving as group A streptococcic tetravalent vaccine protective antigen |
09/29/2010 | CN101845083A Synthetic peptide vaccine for treating porcine reproductive and respiratory syndrome and preparation method thereof |
09/29/2010 | CN101845082A Porcine hemagglutinating encepha lomyelitis virus binding protein and preparation method and use thereof |
09/29/2010 | CN101845079A Hexapeptide or derivative thereof and medical application thereof |
09/29/2010 | CN101843904A Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
09/29/2010 | CN101843895A Cytokine receptor ZCYTOR17 multimers |
09/29/2010 | CN101843641A Novel adenoviruses, nucleic acids coding therefor, and use thereof |
09/29/2010 | CN101323854B Rice RDB1 drought resistant gene |
09/29/2010 | CN101270146B Method for preparing aflatoxin G1 artificial antigen |
09/29/2010 | CN101177453B Recombined chimeric antibody against human tumor necrosis factor alpha |
09/29/2010 | CN101062946B High-active liver regeneration reinforced factor and usage thereof |
09/29/2010 | CN101054414B Method of extracting and preparing deer DGF |
09/29/2010 | CN101029077B Method for purifying gene-recombinant insulin precursor |
09/28/2010 | US7804012 Inbred sweet corn line R605 |
09/28/2010 | US7803989 KCP-like nucleic acids coding polypeptide for use in the generation of disease resistant plants; host cell; plant is maize, soybean, sunflower, sorghum, canola, wheat, alfalfa, cotton, rice, barley, or millet |
09/28/2010 | US7803987 Phosphatase stress-related proteins and methods of use in plants |
09/28/2010 | US7803984 Compositions and methods for controlling plant parasitic nematodes |
09/28/2010 | US7803982 Recombinant rodent comprising mutant g protein coupled receptor for use in identifying modulators of taste; artificial sweetners; flavoring |
09/28/2010 | US7803928 gene silencing is avoided by use of monocot-homeologous sequences from plants of the genus Coix for transformation; isolated DNA molecule that exhibits terminator activity comprising a nucleic acid sequence |
09/28/2010 | US7803927 gene silencing is avoided by use of monocot-homeologous sequences from plants of the genus Coix for transformation; isolated DNA molecule that exhibits terminator activity comprising a nucleic acid sequence |
09/28/2010 | US7803926 Immunology; immunogens; cloning; host cell biosynthesis |
09/28/2010 | US7803924 Polynucleotide encoding a protein that is highly immunogenic especially in fish, and also has utility as a non-specific adjuvant, and as an adjuvanting carrier for heterologous antigens |
09/28/2010 | US7803923 Growth differentiation factor-8 binding agents for treatment of metabolic, nervous system, muscular, bone , urogenital and inflammatory disorders; for treating muscle-wasting disorders and metabolic disorders including diabetes and obesity |
09/28/2010 | US7803918 gene delivery vehicle comprising the isolated and/or recombinant nucleic acid sequence; methods for typing the virus in various samples and diagnosing of disease |
09/28/2010 | US7803916 Comprises urogenital system specific protein for diagnosing and treating tumors; antiproliferative agents; genetic vaccine; 22P4F11 transcript and/or protein represent a useful diagnostic marker and/or therapeutic target for prostate cancer |
09/28/2010 | US7803910 Using allelic variation in cell adhesion molecule (CD164) as tool in treatment and prevntion of skin, arthritic and gastrointestinal disorders |
09/28/2010 | US7803909 Truncated tyrosine kinase for use in identifying modulators for prevention and treatment of cell proliferative disorders |
09/28/2010 | US7803908 pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof |
09/28/2010 | US7803907 Polypeptides comprising monomer domains that bind to c-MET; polynucleotide encoding the polypeptide; cancer |
09/28/2010 | US7803906 Nucleotide sequences and polypeptides; nucleic acids; induce gene expression |
09/28/2010 | US7803905 Comprises genetically engineered matrix proteins immobilized on solid support for implantation, repair and treatment of bone disorders |
09/28/2010 | US7803904 Mucosal vascular addressing and uses thereof |
09/28/2010 | US7803902 comprise peptides that bind target proteins, and that are further modified to have greater protease inhibitory activity and/or be produced at greater yields than the unmodified BBPIs; has a greater trypsin inhibitory activity; used in personal care |
09/28/2010 | US7803901 for inducing a natriuretic (excretion of an excessively large amount of sodium in the urine) or diuretic activity within a mammal |
09/28/2010 | US7803854 Treating diseases caused by an adiponectin receptor-mediated pathway including type II diabetes, insulin resistance, hyperlipidemia, arteriosclerosis, or heart disease by administering an isolated PR-5 protein |
09/28/2010 | US7803791 biological conjugate drug comprising enzyme inhibitor antibiotics and protein, for the treatment and/or prophylaxis of bacterial inflammatory processes, solid tumor; norfloxacin with albumin; antiinflammatory agents, antitumor agents |
09/28/2010 | US7803781 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
09/28/2010 | US7803780 gene therapy of transferring the CD9 gene for suppressing cardiac hypertrophy or cardiac tachycardia in a patient having a heart disease; viral or non-viral expression vector containing a sequence encoding a CD9 protein |
09/28/2010 | US7803774 retro-inverso isomers of beta-amyloid peptides, used for diagnosis and treatment of amyloidogenic diseases such as Alzheimer's disease |
09/28/2010 | US7803772 Administering a polypeptide having at least one of anti-angiogenic, tumor-suppressive, or anti-migratory activity, but does not have stimulation of cell proliferation activity |
09/28/2010 | US7803769 wherein the C-terminal carboxylic acid moiety is replaced; for treating an autoimmune disorder and preventing or mitigating a relapse of a symptom of multiple sclerosis, or treatment of type 1 diabetes, psoriasis, inflammatory bowel disease, Crohn's Disease, ulcerative colitis |
09/28/2010 | US7803766 administering gastrin/(cholecystokinin (CCK) receptor ligand and a factor for complementing gastrin for islet neogenesis therapy; sustained release; for expanding a functional beta cell mass of pancreatic islet transplants; reduces amount of stem cells necessary for treatment; long-acting action |
09/28/2010 | US7803765 production and of nucleic acid fragment libraries that express highly diverse peptides, polypeptides or protein domains and, in particular, nucleic acid fragment libraries wherein the nucleic acid fragments are derived from two or more prokaryote genomes or compact eukaryote genomes |
09/28/2010 | US7803764 Crossing blood-brain barrier; central nervous system disorders; psychological disorders; behavioral disorders |
09/28/2010 | US7803763 Anion/cationic exchanging and chromatography; crystallization |
09/28/2010 | US7803761 Viral capsid proteins and any peptides or compositions thereof for the treatment of pathologic disorders |
09/28/2010 | US7803757 For treatment of urinary tract infections and inflammations, colitis, and candida infections of mucosal membranes; infant formula food containing the peptide |
09/28/2010 | US7803756 Systemic or local administration of a lipopolysaccharide binding polypeptide; neutralizes microbial toxins and allows natural host defence mechanisms to control spread of infection; otitis media; antibiotic resistance |
09/28/2010 | US7803751 contacting target compound with carbodiimide under conditions for preferential addition of carbodiimide to electrophilic moiety over phosphomonoester moiety, and contacting thus-protected target compound with second carbodiimide and nucleophic compound for addition to phosphomonoester |
09/28/2010 | US7803750 Using zinc glycoprotein |
09/28/2010 | US7803749 Prevent signal transduction passageways; kinase inhibitor; modulate immunology response |